Gsk (GSK) Goodwill & Intangibles (2009 - 2026)

Gsk (GSK) has 18 years of Goodwill & Intangibles data on file, last reported at $32.4 billion in Q2 2026.

• For the quarter ending Q2 2026, Goodwill & Intangibles rose 10.0% year-over-year to $32.4 billion; the trailing twelve-month figure through Jun 2026 stood at $32.4 billion (up 10.0% YoY), and the FY2025 full-year result was $31.6 billion, up 9.93% from the prior year.
• Goodwill & Intangibles was $32.4 billion for Q2 2026 at Gsk, down from $34.3 billion in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $37.2 billion in Q1 2022 to a low of $21.8 billion in Q2 2022.
• A 5-year average of $29.0 billion and a median of $28.5 billion in 2024 frame the typical range for Goodwill & Intangibles.
• Across the five-year window, Goodwill & Intangibles slumped 60.86% in 2022 and grew 27.95% in 2023, its largest moves.
• Gsk's Goodwill & Intangibles stood at $25.1 billion in 2022, then increased by 6.88% to $26.8 billion in 2023, then increased by 7.81% to $28.9 billion in 2024, then grew by 9.48% to $31.6 billion in 2025, then increased by 2.64% to $32.4 billion in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $32.4 billion in Q2 2026, $34.3 billion in Q1 2026, and $31.6 billion in Q4 2025.